Literature DB >> 17999878

Azole prophylaxis to prevent invasive fungal infections in patients with severe graft-versus-host disease.

Stanley W Chapman.   

Abstract

Entities:  

Year:  2007        PMID： 17999878

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  12 in total

1.  Prophylaxis and aspergillosis--has the principle been proven?

Authors:  Ben E De Pauw; J Peter Donnelly
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

2.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Authors:  Andrew J Ullmann; Jeffrey H Lipton; David H Vesole; Pranatharthi Chandrasekar; Amelia Langston; Stefano R Tarantolo; Hildegard Greinix; Wellington Morais de Azevedo; Vijay Reddy; Navdeep Boparai; Lisa Pedicone; Hernando Patino; Simon Durrant
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

3.  Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC).

Authors:  C Viscoli; C Girmenia; A Marinus; L Collette; P Martino; B Vandercam; C Doyen; B Lebeau; D Spence; V Krcmery; B De Pauw; F Meunier
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

Review 4.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 5.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

Authors:  E I Boutati; E J Anaissie
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

Review 6.  Aspergillosis case-fatality rate: systematic review of the literature.

Authors:  S J Lin; J Schranz; S M Teutsch
Journal:  Clin Infect Dis       Date:  2001-01-26       Impact factor: 9.079

7.  Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation.

Authors:  P Ribaud; C Chastang; J P Latgé; L Baffroy-Lafitte; N Parquet; A Devergie; H Espérou; F Sélimi; V Rocha; H Espérou; F Sélimi; V Rocha; F Derouin; G Socié; E Gluckman
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

8.  Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.

Authors:  C Rotstein; E J Bow; M Laverdiere; S Ioannou; D Carr; N Moghaddam
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

Review 9.  Posaconazole: clinical pharmacology and potential for management of fungal infections.

Authors:  Andreas H Groll; Thomas J Walsh
Journal:  Expert Rev Anti Infect Ther       Date:  2005-08       Impact factor: 5.091

10.  Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

Authors:  M A Slavin; B Osborne; R Adams; M J Levenstein; H G Schoch; A R Feldman; J D Meyers; R A Bowden
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.